Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands

Vaccines
Deana N Toussi, Paola Massari

Abstract

Vaccine efficacy is optimized by addition of immune adjuvants. However, although adjuvants have been used for over a century, to date, only few adjuvants are approved for human use, mostly aimed at improving vaccine efficacy and antigen-specific protective antibody production. The mechanism of action of immune adjuvants is diverse, depending on their chemical and molecular nature, ranging from non-specific effects (i.e., antigen depot at the immunization site) to specific activation of immune cells leading to improved host innate and adaptive responses. Although the detailed molecular mechanism of action of many adjuvants is still elusive, the discovery of Toll-like receptors (TLRs) has provided new critical information on immunostimulatory effect of numerous bacterial components that engage TLRs. These ligands have been shown to improve both the quality and the quantity of host adaptive immune responses when used in vaccine formulations targeted to infectious diseases and cancer that require both humoral and cell-mediated immunity. The potential of such TLR adjuvants in improving the design and the outcomes of several vaccines is continuously evolving, as new agonists are discovered and tested in experimental and clinical mode...Continue Reading

References

Oct 1, 1975·The Journal of Infectious Diseases·H B LevyJ Rice
Sep 21, 1990·Science·R R SchumannR J Ulevitch
Sep 1, 1989·Immunology Today·C Janeway
Mar 1, 1985·International Journal of Radiation Oncology, Biology, Physics·J E ByfieldJ C Griffiths
Feb 1, 1970·Proceedings of the Society for Experimental Biology and Medicine·J J NordlundH B Levy
Jan 1, 1994·Annual Review of Immunology·P Matzinger
Jan 1, 1993·Vaccine·R K GuptaC K Gupta
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·D M KlinmanA M Krieg
Mar 1, 1996·The Journal of Experimental Medicine·L M WetzlerL W Wetzler
Jun 15, 1996·Structure·F van den AkkerW G Hol
Apr 10, 1999·The Journal of Biological Chemistry·J C ChowF Gusovsky
Aug 7, 1999·The Journal of Infectious Diseases·F G MackinnonL M Wetzler
Aug 28, 1999·Bioorganic & Medicinal Chemistry Letters·D A JohnsonV G Brookshire
Feb 26, 2000·Vaccine·K FujihashiJ R McGhee
Nov 9, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·G A BishopM A Tomai
Dec 21, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·E H NardinK Rose
Feb 13, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·D VerthelyiD M Klinman
Mar 21, 2001·Vaccine·S ThoelenN Tornieporth
Jun 30, 2001·International Immunology·O TakeuchiS Akira
Jul 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·S BauerG B Lipford
Nov 3, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·I ArevaloA Llanos-Cuentas
Mar 23, 2002·Biochimica Et Biophysica Acta·Tsuneyasu Kaisho, Shizuo Akira
Apr 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Veit HornungGunther Hartmann
May 3, 2002·The Journal of Biological Chemistry·Daisuke IwakiYoshio Kuroki

❮ Previous
Next ❯

Citations

Feb 16, 2016·Expert Opinion on Investigational Drugs·Masaud ShahSangdun Choi
Sep 18, 2016·Medical Mycology·Taise Natali LandgrafAdemilson Panunto-Castelo
Nov 11, 2016·Cancer Immunology, Immunotherapy : CII·Luisa CircelliLuigi Buonaguro
Dec 6, 2017·Journal of Immunology Research·Jonathan LaiñoStefan Schülke
Jul 24, 2018·Journal of Biomolecular Structure & Dynamics·Soudabeh SabetianYounes Ghasemi
Apr 23, 2019·Expert Review of Vaccines·Indranil SarkarSylvia van Drunen Littel-van den Hurk
Mar 30, 2019·Endocrine, Metabolic & Immune Disorders Drug Targets·Tugba AktaşAhmet Dursun
Jul 18, 2019·NPJ Vaccines·Puthupparampil V ScariaPatrick E Duffy
Aug 26, 2020·Expert Opinion on Drug Discovery·Fakhriedzwan IdrisSylvie Alonso
Mar 25, 2017·Frontiers in Immunology·Marisol Pérez-ToledoConstantino López-Macías
May 31, 2019·Journal of Cellular Physiology·Ana Patricia Ayala-CuellarKyung-Chul Choi
Apr 8, 2017·Scandinavian Journal of Immunology·A K VyasN Trehanpati
Nov 5, 2019·Frontiers in Immunology·Amanda B MacedoAlberto Bosque
Mar 18, 2017·International Journal of Molecular Sciences·Suneetha Amara, Venkataswarup Tiriveedhi
Sep 16, 2017·International Journal of Endocrinology·Won Kyoung ChoByung-Kyu Suh
Aug 28, 2019·Current Immunology Reviews·Pamela A Kozlowski, Anna Aldovini
Feb 23, 2019·NPJ Vaccines·Wei Sun, Amit K Singh
Jun 25, 2020·International Journal of Molecular Sciences·Francesca ManciniFrancesca Micoli
Feb 5, 2019·Current Molecular Medicine·Shirin MahmoodiYounes Ghasemi
Aug 11, 2020·Journal of Biomolecular Structure & Dynamics·Bishajit SarkarMohammad Jakir Hosen
Jan 13, 2019·Journal of Biomolecular Structure & Dynamics·Hesam DorostiYounes Ghasemi
Nov 7, 2017·Immunology Letters·Mahyar Nouri-ShiraziElisabeth Guinet
May 3, 2021·The FEBS Journal·Marko AnderluhSandra J van Vliet
Dec 22, 2020·Journal of Medicinal Chemistry·Arshpreet KaurDeepak B Salunke
Oct 20, 2017·ACS Biomaterials Science & Engineering·Sema SevimliJohn T Wilson

❮ Previous
Next ❯

Methods Mentioned

BETA
RIP
acylation

Software Mentioned

Theratope

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Trends in Immunology
David van DuinAlbert C Shaw
Expert Review of Vaccines
Manoli Igartua, José Luís Pedraz
Current Opinion in Immunology
M Lamine MbowRino Rappuoli
Frontiers in Immunology
Sunita AwateGeorge Mutwiri
Current Opinion in Pharmacology
Aisling DunneKingston H G Mills
© 2021 Meta ULC. All rights reserved